penne arrabbiata
Selected indexed studies
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. (N Engl J Med, 2021) [PMID:34449181]
- Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. (N Engl J Med, 2025) [PMID:40305708]
- Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial. (JAMA, 2024) [PMID:39212270]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. (2021) pubmed
- Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. (2025) pubmed
- Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial. (2024) pubmed
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. (2022) pubmed
- Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure. (2023) pubmed
- Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis. (2022) pubmed
- Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis. (2023) pubmed
- Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis. (2023) pubmed
- Primary cutaneous T-follicular helper lymphoma. (2023) pubmed
- [Disillusioned purposes]. (1975) pubmed